Cutting edge: Engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset

被引:80
作者
Barakonyi, A
Rabot, M
Marie-Cardine, A
Aguerre-Girr, M
Polgar, B
Schiavon, V
Bensussan, A
Le Bouteiller, P
机构
[1] Fac Med Creteil, INSERM U448, F-94010 Creteil, France
[2] Hop Purpan, INSERM U563, Ctr Physiopathol Toulouse Purpan, F-31024 Toulouse 3, France
关键词
D O I
10.4049/jimmunol.173.9.5349
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD160 is an Ig-like activating NK cell receptor expressed on the majority of circulating NK cells. This population corresponds to the nonproliferating, highly cytolytic, CD57(dim) CD16(+) subset. CD160 engagement by HLA-C molecules mediates cytotoxic function. In this study, we report that upon specific activation by the physiological ligand HLA-C, or A cross-linking, CD160(+) peripheral blood NK cells produce IFN-gamma, TNF-alpha, and IL-6 This unique CD160-mediated cytokine production differs from the one observed after CD16 engagement whose expression is also restricted to the CD56(dim) cytotoxic NK cell subset. As already reported for the CD160-mediated cytotoxic effector function, CD160-mediated cytokine production by peripheral blood-NK cells is negatively controlled by the killer Ig-like receptor CD158b. Thus, the CD160 receptor represents a unique triggering surface molecule expressed by cytotoxic NK cells that participates in the inflammatory response and determines the type of subsequent specific immunity.
引用
收藏
页码:5349 / 5354
页数:6
相关论文
共 19 条
[1]  
Agrawal S, 1999, J IMMUNOL, V162, P1223
[2]   Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors [J].
André, P ;
Castriconi, R ;
Espéli, M ;
Anfossi, N ;
Juarez, T ;
Hue, S ;
Conway, H ;
Romagné, F ;
Dondero, A ;
Nanni, M ;
Caillat-Zucman, S ;
Raulet, DH ;
Bottino, C ;
Vivier, E ;
Moretta, A ;
Paul, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (04) :961-971
[3]  
Anumanthan A, 1998, J IMMUNOL, V161, P2780
[4]   Recognition of infected cells by natural killer cells [J].
Carayannopoulos, LN ;
Yokoyama, WM .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (01) :26-33
[5]   Natural killer cells, viruses and cancer [J].
Cerwenka, A ;
Lanier, LL .
NATURE REVIEWS IMMUNOLOGY, 2001, 1 (01) :41-49
[6]   Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry, allergies vs. non-allergies [J].
Cook, EB ;
Stahl, JL ;
Lowe, L ;
Chen, R ;
Morgan, E ;
Wilson, J ;
Varro, R ;
Chan, A ;
Graziano, FM ;
Barney, NP .
JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 254 (1-2) :109-118
[7]   The biology of human natural killer-cell subsets [J].
Cooper, MA ;
Fehniger, TA ;
Caligiuri, MA .
TRENDS IN IMMUNOLOGY, 2001, 22 (11) :633-640
[8]   NK cell compartments and their activation by dendritic cells [J].
Ferlazzo, G ;
Münz, C .
JOURNAL OF IMMUNOLOGY, 2004, 172 (03) :1333-1339
[9]   The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic [J].
Ferlazzo, G ;
Thomas, D ;
Lin, SL ;
Goodman, K ;
Morandi, B ;
Muller, WA ;
Moretta, A ;
Münz, C .
JOURNAL OF IMMUNOLOGY, 2004, 172 (03) :1455-1462
[10]   Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-β1 and restores the lymphokine-activated killing activity [J].
Hsiao, YW ;
Liao, KW ;
Hung, SW ;
Chu, RM .
JOURNAL OF IMMUNOLOGY, 2004, 172 (03) :1508-1514